✦ LIBER ✦

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy

✍ Scribed by Lu, Shasha; Xu, Yu; Mu, Qitian; Cao, Lihong; Chen, Jian; Zhu, Zhijuan; Lou, Yinjun; Meng, Haitao; Qian, Wenbin; Tong, Hongyan; Mai, Wenyuan; Huang, Jian; Yu, Wenjuan; Zhao, Xiaoying; Jin, Jie

Book ID: 125834945
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 707 KB
Volume: 56
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2014.947606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of hepatitis B virus (HBV) reactiva

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

✍ Yu Xuan Koo; Matthew Tay; Yii Ean Teh; David Teng; Daniel S. W. Tan; Iain B. H. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 92 KB

The effect of prophylactic lamivudine on

The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy

✍ Xiao-Qin Chen, Jie-Wen Peng, Gui-Nan Lin, Mei Li, Zhong-Jun Xia 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 162 KB

Hepatitis B virus reactivation in hepati

Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors

✍ Gui-Nan Lin,Jie-Wen Peng,Jian-jun Xiao,Dong-Ying Liu,Zhong-Jun Xia 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 177 KB